Work

A state-dependent glymphatic dimension in major depressive disorder: implications for treatment resistance

Year: 2026
Type: review
Abstract: The glymphatic system refers to cerebrospinal fluid-interstitial fluid exchange and proposed drainage pathways shaped by sleep, arousal, vascular dynamics, and astrocytic organization. This physiology offers a way to connect disturbances that often coexist in major depressive disorder (MDD): disrupted sleep, fatigue, cognitive slowing, and stress-related abnormalities. We propose that difficulty establishing or maintaining a coordinated sleep-astrocyte-vascular state may contribute to illness persistence in some patients. Treatment-resistant depression (TRD) provides a setting in which this possibility can be examined across the course of treatment. Preclinical studies link stress and depressive-like behavior to astrocytic injury, aquaporin-4 dysregulation, and altered fluid transport. Human imaging findings vary across depressive phenotypes. In a dedicated TRD study, a higher diffusion tensor imaging along the perivascular space (DTI-ALPS) ratio was partly driven by reduced denominator diffusivity, illustrating the importance of interpreting this indirect index at component level. Whole-brain spatiotemporal models provide a complementary account of the neural activity accompanying these physiological states. Ketamine/esketamine, transcranial magnetic stimulation, and chronobiological interventions offer different ways to investigate treatment-related change; serotonergic psychedelics provide an exploratory extension. Longitudinal studies can establish how changes in sleep, fluid-sensitive imaging, and neural dynamics relate temporally to clinical recovery. This Perspective therefore develops a potentially modifiable physiological dimension of persistent depressive illness and defines how it can be tested.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $5,490
OpenAlex ID: W7236589521
FWCI:
Cites: 71
Cited by:
Related to: 10